{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T21:48:57Z","timestamp":1649022537062},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2000,2,1]],"date-time":"2000-02-01T00:00:00Z","timestamp":949363200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Cardio Med"],"published-print":{"date-parts":[[2000,2]]},"DOI":"10.1007\/s11936-000-0027-9","type":"journal-article","created":{"date-parts":[[2007,6,3]],"date-time":"2007-06-03T03:42:46Z","timestamp":1180842166000},"page":"37-53","source":"Crossref","is-referenced-by-count":0,"title":["Unstable angina"],"prefix":"10.1007","volume":"2","author":[{"given":"M. Bilal","family":"Murad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy D.","family":"Henry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"27_CR1","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/S0140-6736(72)90737-4","volume":"1","author":"M Fulton","year":"1972","unstructured":"Fulton M, Lutz W, Donald KW, et al.: Natural history of unstable angina. Lancet 1972, 1:860\u2013865.","journal-title":"Lancet"},{"key":"27_CR2","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/S0735-1097(98)00140-5","volume":"31","author":"RT Domburg","year":"1998","unstructured":"Domburg RT, Miltenburg-van Zijl AJ, Veerhoek RJ, et al.: Unstable angina: good long-term outcome after a complicated early course. J Am Coll Cardiol 1998, 31:1534\u20131539.","journal-title":"J Am Coll Cardiol"},{"key":"27_CR3","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1056\/NEJM199805213382103","volume":"338","author":"The PRISM Study Investigators","year":"1998","unstructured":"The PRISM Study Investigators: A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina. N Engl J Med 1998, 338:1498\u20131505.","journal-title":"N Engl J Med"},{"key":"27_CR4","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1056\/NEJM199609123351103","volume":"335","author":"The GUSTO IIb Investigators","year":"1996","unstructured":"The GUSTO IIb Investigators: A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes. N Engl J Med 1996, 335:775\u2013782.","journal-title":"N Engl J Med"},{"key":"27_CR5","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1161\/01.CIR.90.1.613","volume":"90","author":"E Braunwald","year":"1994","unstructured":"Braunwald E, Jones RH, Mark DB, et al.: Diagnosing and managing unstable angina. AHCPR guidelines for unstable angina. Circulation 1994, 90:613\u2013622. Essential reading to understand the rationale behind clinical practice.","journal-title":"Circulation"},{"key":"27_CR6","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1161\/01.CIR.98.25.2829","volume":"98","author":"DF Kong","year":"1998","unstructured":"Kong DF, Califf RM, Miller DP, et al.: Clinical outcomes of therapeutic agents that block the platelet glycoprotein IIb\/IIIa integrin in ischemic heart disease. Circulation 1998, 98:2829\u20132835. Review of all interventional and acute coronary syndrome trials that evaluate the efficacy of treatment with glycoprotein IIb\/IIIa inhibitors.","journal-title":"Circulation"},{"issue":"9","key":"27_CR7","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3949\/ccjm.66.9.561","volume":"66","author":"V Patel","year":"1999","unstructured":"Patel V, Topol E: The pathogenesis and spectrum of acute coronary syndromes: from plaque formation to thrombosis. Cleve Clin J Med 1999, 66(9):561\u2013571.","journal-title":"Cleve Clin J Med"},{"key":"27_CR8","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/S0735-1097(97)00213-1","volume":"30","author":"C Depre","year":"1997","unstructured":"Depre C, Wijns W, Robert AM, et al.: Pathology of unstable plaque: correlation with clinical severity of acute coronary syndromes. J Am Coll Cardiol 1997, 30:694\u2013702.","journal-title":"J Am Coll Cardiol"},{"key":"27_CR9","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1161\/01.CIR.97.12.1195","volume":"97","author":"R Theroux","year":"1998","unstructured":"Theroux R, Fuster V: Acute coronary syndromes: unstable angina and non-Q wave MI. Circulation 1998, 97:1195\u20131206. An outstanding, updated, comprehensive review addressing the spectrum of disease, established and potential pathophysiologic concepts, risk stratification, and management issues.","journal-title":"Circulation"},{"issue":"2","key":"27_CR10","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1161\/01.CIR.80.2.410","volume":"80","author":"E Braunwald","year":"1989","unstructured":"Braunwald E. Unstable angina: a classification. Circulation 1989, 80(2):410\u2013414.","journal-title":"Circulation"},{"key":"27_CR11","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1161\/01.CIR.91.10.2541","volume":"91","author":"FV Aguirre","year":"1995","unstructured":"Aguirre FV, Younis LL, Chaitman BR, et al.: Early and 1 year clinical outcome of patients evolving non-Q wave versus Q-wave MI after thrombolysis: results from the TIMI II study. Circulation 1995, 91:2541\u20132548.","journal-title":"Circulation"},{"key":"27_CR12","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1097\/00019501-199412000-00008","volume":"5","author":"W Zareba","year":"1994","unstructured":"Zareba W, Moss AJ, Raubertas RF, et al.: Risk of subsequent cardiac events in stable convalescing patients after first non-Q wave and Q-wave MI. Coron Artery Dis 1994, 5:1009\u20131018.","journal-title":"Coron Artery Dis"},{"key":"27_CR13","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1056\/NEJM199610313351802","volume":"335","author":"EM Antman","year":"1996","unstructured":"Antman EM, Tanasijevic MJ, Thompson B, et al.: Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 1996, 335:1342\u20131349.","journal-title":"N Engl J Med"},{"key":"27_CR14","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1056\/NEJM199610313351801","volume":"335","author":"EM Ohman","year":"1996","unstructured":"Ohman EM, Armstrong PW, Christenson RH, et al.: Cardiac troponin T levels for risk stratification in acute myocardial ischemia. N Engl J Med 1996, 335:1333\u20131341.","journal-title":"N Engl J Med"},{"key":"27_CR15","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S0002-9149(98)00411-1","volume":"82","author":"R Moreno","year":"1998","unstructured":"Moreno R, Lopez de Sa E, Lopez-Sendon JL, et al.: Prognosis of medically stabilized unstable angina with a negative exercise test. Am J Cardiol 1998, 82:662\u2013665.","journal-title":"Am J Cardiol"},{"key":"27_CR16","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0735-1097(97)00160-5","volume":"30","author":"CP Cannon","year":"1997","unstructured":"Cannon CP, McCabe CH, Stone PH, et al.: The electrocardiogram predicts one-year outcome of patients with unstable angina and non-Q wave MI: results of the TIMI III registry ECG ancillary study. J Am Coll Cardiol 1997, 30:133\u2013140.","journal-title":"J Am Coll Cardiol"},{"key":"27_CR17","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/0735-1097(92)90633-X","volume":"19","author":"A Betriu","year":"1992","unstructured":"Betriu A, Heras M, Cohen M, et al.: Unstable angina: outcome according to clinical presentation. J Am Coll Cardiol 1992, 19:1659\u20131663.","journal-title":"J Am Coll Cardiol"},{"key":"27_CR18","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0735-1097(97)00110-1","volume":"30","author":"AM Lincoff","year":"1997","unstructured":"Lincoff AM, Califf RM, Anderson KM, et al.: Evidence for prevention of death and MI with platelet membrane GP IIb\/IIIa receptor blockade by abciximab (c7E3 Fab) among patients with unstable angina undergoing percutaneous coronary revascularization. J Am Coll Cardiol 1997, 30:149\u2013156.","journal-title":"J Am Coll Cardiol"},{"key":"27_CR19","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/S0140-6736(96)10452-9","volume":"349","author":"The CAPTURE Investigators","year":"1997","unstructured":"The CAPTURE Investigators: Randomized placebocontrolled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE study. Lancet 1997, 349:1429\u20131435.","journal-title":"Lancet"},{"key":"27_CR20","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM199511163332001","volume":"333","author":"J Shepherd","year":"1995","unstructured":"Shepherd J, Cobbe SM, Ford I, et al.: Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med 1995, 333:1301\u20131307.","journal-title":"N Engl J Med"},{"key":"27_CR21","first-page":"1383","volume":"344","author":"The Scandinavian Simvastatin Survival Study","year":"1994","unstructured":"The Scandinavian Simvastatin Survival Study: Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994, 344:1383\u20131389.","journal-title":"Lancet"},{"key":"27_CR22","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199811053391902","volume":"339","author":"The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group","year":"1998","unstructured":"The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group: Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad base of initial cholesterol levels. N Engl J Med 1998, 339:1349\u20131357.","journal-title":"N Engl J Med"},{"key":"27_CR23","doi-asserted-by":"crossref","unstructured":"The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997, 157(21):2413-2446.","DOI":"10.1001\/archinte.1997.00440420033005"},{"key":"27_CR24","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/bmj.308.6921.81","volume":"308","author":"Antiplatelet Trialists\u2019 Collaboration","year":"1994","unstructured":"Antiplatelet Trialists\u2019 Collaboration: Collaborative review of randomized trials of anti-platelet therapy. I. Prevention of death, MI, and stroke by prolonged anti-platelet therapy in various categories of patients. BMJ 1994, 308:81\u2013106.","journal-title":"BMJ"},{"issue":"17","key":"27_CR25","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1056\/NEJM198810273191701","volume":"319","author":"R Theroux","year":"1988","unstructured":"Theroux R, Ouimet H, McCans J, et al.: Aspirin, heparin or both to treat acute unstable angina. N Engl J Med 1988, 319(17):1105\u20131111.","journal-title":"N Engl J Med"},{"key":"27_CR26","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0140-6736(90)92336-G","volume":"336","author":"The RISC Group","year":"1990","unstructured":"The RISC Group: Risk of MI and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease. Lancet 1990, 336:827\u2013830.","journal-title":"Lancet"},{"key":"27_CR27","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1056\/NEJM198308183090703","volume":"309","author":"HD Lewis","year":"1983","unstructured":"Lewis HD, Davis JW, Archibald DG, et al.: Protective effects of aspirin against MI and death in men with unstable angina. N Engl J Med 1983, 309:396\u2013403.","journal-title":"N Engl J Med"},{"key":"27_CR28","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1056\/NEJM198511283132201","volume":"313","author":"JA Cairns","year":"1985","unstructured":"Cairns JA, Gent M, Singer J, et al.: Aspirin, sulfinpyrazone or both in unstable angina. N Engl J Med 1985, 313:1369\u20131375.","journal-title":"N Engl J Med"},{"key":"27_CR29","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1161\/01.CIR.82.1.17","volume":"82","author":"F Balsano","year":"1990","unstructured":"Balsano F, Rizzon P, Violi F, et al. for the Studio della Ticlopidina nell\u2019Angina Instabile Group: Antiplatelet treatment with ticlopidine in unstable angina: a controlled multi-center clinical trial. Circulation 1990, 82:17\u201326.","journal-title":"Circulation"},{"issue":"9038","key":"27_CR30","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","volume":"348","author":"CAPRIE Steering Committee","year":"1996","unstructured":"CAPRIE Steering Committee: A randomized, blinded, trial of clopidogrel versus aspirin in patients at risk of ischemic events (CAPRIE). Lancet 1996, 348(9038):1329\u20131339.","journal-title":"Lancet"},{"key":"27_CR31","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1056\/NEJM199805213382102","volume":"338","author":"The PRISM-PLUS Study Investigators","year":"1998","unstructured":"The PRISM-PLUS Study Investigators: Inhibition of the platelet GP IIb\/IIIa receptor with tirofiban in unstable angina and non-Q wave MI. The platelet receptor inhibition in ischemic syndrome in patients limited by unstable signs and symptoms. N Engl J Med 1998, 338:1488\u20131497.","journal-title":"N Engl J Med"},{"key":"27_CR32","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1056\/NEJM199808133390704","volume":"339","author":"The PURSUIT Trial Investigators","year":"1998","unstructured":"The PURSUIT Trial Investigators: Inhibition of platelet GP IIb\/IIIa with eptifibatide in patients with acute coronary syndromes. N Engl J Med 1998, 339:436\u2013443.","journal-title":"N Engl J Med"},{"key":"27_CR33","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1161\/01.CIR.97.24.2386","volume":"97","author":"The PARAGON Investigators","year":"1998","unstructured":"The PARAGON Investigators: International, randomized, controlled trial of lamifiban, heparin, or both in unstable angina. Circulation 1998, 97:2386\u20132395.","journal-title":"Circulation"},{"key":"27_CR34","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1001\/jama.1997.03550060055036","volume":"278","author":"EJ Topol","year":"1997","unstructured":"Topol EJ, Ferguson JJ, Weismann HF, et al.: Long term protection from myocardial ischemic events after brief integrin b1 blockade with percutaneous coronary intervention. JAMA 1997, 278:479\u2013484.","journal-title":"JAMA"},{"key":"27_CR35","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1161\/01.CIR.94.4.629","volume":"94","author":"DB Mark","year":"1996","unstructured":"Mark DB, Talley D, Topol EJ, et al.: Economic assessment of platelet GP IIb\/IIIa inhibition for prevention of ischemic complications of high-risk coronary angioplasty. Circulation 1996, 94:629\u2013635.","journal-title":"Circulation"},{"key":"27_CR36","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1161\/01.CIR.97.3.251","volume":"97","author":"Z Xiao","year":"1998","unstructured":"Xiao Z, Theroux P: Platelet activation with UFH at therapeutic concentrations and comparisons with a low-molecular-weight heparin and with a direct thrombin inhibitor. Circulation 1998, 97:251\u2013256.","journal-title":"Circulation"},{"issue":"3","key":"27_CR37","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1056\/NEJM199207163270301","volume":"327","author":"P Theroux","year":"1992","unstructured":"Theroux P, Waters D, Lam J, et al.: Reactivation of unstable angina after the discontinuation of heparin. N Engl J Med 1992, 327(3):141\u2013145.","journal-title":"N Engl J Med"},{"key":"27_CR38","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/S0140-6736(81)92399-0","volume":"1","author":"AM Telford","year":"1981","unstructured":"Telford AM, Wilson C: Trial of heparin versus atenolol in prevention of MI in intermediate coronary syndrome. Lancet 1981, 1:1225\u20131228.","journal-title":"Lancet"},{"key":"27_CR39","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0735-1097(94)90539-8","volume":"24","author":"D Holdright","year":"1994","unstructured":"Holdright D, Patel D, Cunningham D, et al.: Comparison of the effect of heparin and aspirin versus aspirin alone on transient myocardial ischemia and in-hospital prognosis in patients with unstable angina. J Am Coll Cardiol 1994, 24:39\u201345.","journal-title":"J Am Coll Cardiol"},{"key":"27_CR40","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1161\/01.CIR.88.5.2045","volume":"88","author":"P Theroux","year":"1993","unstructured":"Theroux P, Waters D, Qui S, et al.: Aspirin versus heparin to prevent MI during the acute phase of unstable angina. Circulation 1993, 88(part 1):2045\u20132048.","journal-title":"Circulation"},{"key":"27_CR41","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0735-1097(95)80001-W","volume":"26","author":"EP Gurfinkel","year":"1995","unstructured":"Gurfinkel EP, Manos EJ, Mejail RI, et al.: Low molecular weight heparin versus regular heparin or aspirin in the treatment of unstable angina and silent ischemia. J Am Coll Cardiol 1995, 26:313\u2013318.","journal-title":"J Am Coll Cardiol"},{"key":"27_CR42","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0140-6736(96)91270-2","volume":"347","author":"Fragmin during Instability in Coronary Artery Disease (FRISC) Study Group","year":"1996","unstructured":"Fragmin during Instability in Coronary Artery Disease (FRISC) Study Group: Low-molecular weight heparin during instability in coronary artery disease. Lancet 1996, 347:561\u2013568.","journal-title":"Lancet"},{"key":"27_CR43","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1161\/01.CIR.96.1.61","volume":"96","author":"W Klein","year":"1997","unstructured":"Klein W, Buchwald A, Hillis SE, et al.: Comparison of low-molecular-weight heparin with unfractionated heparin acutely and with placebo for 6 weeks in the management of unstable coronary artery disease: Fragmin in Unstable Coronary Artery Disease Study (FRIC). Circulation 1997, 96:61\u201368.","journal-title":"Circulation"},{"key":"27_CR44","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1056\/NEJM199708143370702","volume":"337","author":"M Cohen","year":"1997","unstructured":"Cohen M, Demers C, Gurfinkel EP, et al. for the ESSENCE Study Group: A comparison of lowmolecular weight heparin with unfractionated heparin for unstable coronary artery disease. N Engl J Med 1997, 337:447\u2013452.","journal-title":"N Engl J Med"},{"key":"27_CR45","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1161\/01.CIR.100.15.1593","volume":"100","author":"EM Antman","year":"1999","unstructured":"Antman EM, McCabe CH, Gurfinkel EP, et al.: Enoxaparin prevents death and cardiac ischemic events in unstable angina\/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11b trial. Circulation 1999, 100:1593\u20131601.","journal-title":"Circulation"},{"issue":"17","key":"27_CR46","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1161\/01.CIR.97.17.1702","volume":"97","author":"DB Mark","year":"1998","unstructured":"Mark DB, Cowper PA, Berkowitz SD, et al.: Economic assessment of low-molecular-weight-heparin (enoxaparin) versus unfractionated heparin in acute coronary syndrome patients: results from the ESSENCE randomized trial. Circulation 1998, 97(17):1702\u20131707.","journal-title":"Circulation"},{"key":"27_CR47","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1161\/01.CIR.89.4.1557","volume":"89","author":"EJ Topol","year":"1994","unstructured":"Topol EJ, Fuster V, Harrington RA, et al.: Recombinant hirudin for unstable angina pectoris. A multicenter, randomized angiographic trial. Circulation 1994, 89:1557\u20131566.","journal-title":"Circulation"},{"key":"27_CR48","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1056\/NEJM199609123351103","volume":"335","author":"The GUSTO IIb Investigators","year":"1996","unstructured":"The GUSTO IIb Investigators: A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes. N Engl J Med 1996, 335:775\u2013782.","journal-title":"N Engl J Med"},{"key":"27_CR49","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1161\/01.CIR.92.4.727","volume":"92","author":"J Fuchs","year":"1995","unstructured":"Fuchs J, Cannon CP, and the TIMI 7 Investigators: Hirulog in the treatment of unstable angina. Results of the Thrombin Inhibition in Myocardial Ischemia (TIMI) 7 trial. Circulation 1995, 92:727\u2013733.","journal-title":"Circulation"},{"key":"27_CR50","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0140-6736(98)07332-2","volume":"353","author":"OASIS-2 Investigators","year":"1999","unstructured":"OASIS-2 Investigators: Effects of recombinant hirudin (lepirudin) compared with heparin on death, MI, refractory angina, and revascularization procedures in patients with acute myocardial ischemia without ST elevation: a randomized trial. Lancet 1999, 353:429\u2013438.","journal-title":"Lancet"},{"key":"27_CR51","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/hrt.59.2.270","volume":"59","author":"T Weihrauch","year":"1988","unstructured":"Weihrauch T, Baumann J, Ebner F: Early treatment of unstable angina in the coronary care unit: a randomised, double blind, placebo controlled comparison of recurrent ischaemia in patients treated with nifedipine or metoprolol or both. Br Heart J 1988, 59:270\u2013272.","journal-title":"Br Heart J"},{"key":"27_CR52","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0735-1097(85)80400-9","volume":"5","author":"P Theroux","year":"1985","unstructured":"Theroux P, Taeymans Y, Morissette D, et al.: A randomized study comparing propranolol and diltiazem in the treatment of unstable angina. J Am Coll Cardiol 1985, 5:717\u2013722.","journal-title":"J Am Coll Cardiol"},{"key":"27_CR53","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/S0735-1097(98)00408-2","volume":"32","author":"NL Smith","year":"1998","unstructured":"Smith NL, Reiber GE, Psaty BM, et al.: Health outcomes associated with beta-blocker and diltiazem treatment of unstable angina. J Am Coll Cardiol 1998, 32:1305\u20131311.","journal-title":"J Am Coll Cardiol"},{"issue":"15","key":"27_CR54","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1001\/jama.1988.03410150107041","volume":"260","author":"S Yusuf","year":"1988","unstructured":"Yusuf S, Wittes J, Friedman L: Overview of results of randomized clinical trials in heart disease II: unstable angina, heart failure, primary prevention with aspirin, and risk factor modification. JAMA 1988, 260(15):2259\u20132263.","journal-title":"JAMA"},{"key":"27_CR55","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1056\/NEJM199808203390801","volume":"339","author":"SS Gottlieb","year":"1998","unstructured":"Gottlieb SS, McCarter RJ, Vogel RA, et al.: Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. N Engl J Med 1998, 339:489\u2013497.","journal-title":"N Engl J Med"},{"key":"27_CR56","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/0735-1097(95)00404-1","volume":"26","author":"HV Anderson","year":"1995","unstructured":"Anderson HV, Cannon CP, Stone PH, et al.: One-year results of the TIMI IIIb clinical trial. J Am Coll Cardiol 1995, 26:1643\u20131650.","journal-title":"J Am Coll Cardiol"},{"key":"27_CR57","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1056\/NEJM199806183382501","volume":"338","author":"WE Boden","year":"1998","unstructured":"Boden WE, O\u2019Rourke RA, Crawford MH, et al.: Outcomes in patients with acute non-Q wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. N Engl J Med 1998, 338:1785\u20131792.","journal-title":"N Engl J Med"},{"key":"27_CR58","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0002-9149(98)00540-2","volume":"82","author":"CP Cannon","year":"1998","unstructured":"Cannon CP, Weintraub WS, Demopoulos LA, et al.: Invasive versus conservative strategies in unstable angina and non-Q wave MI following treatment with tirofiban: rationale and study design of the international TACTICS-TIMI 18 trial. Am J Cardiol 1998, 82:731\u2013736.","journal-title":"Am J Cardiol"},{"key":"27_CR59","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S0140-6736(99)07349-3","volume":"354","author":"Fragmin and Fast Revascularisation during InStability in Coronary artery disease Investigators","year":"1999","unstructured":"Fragmin and Fast Revascularisation during InStability in Coronary artery disease Investigators: Invasive compared with non-invasive treatment in unstable coronary-artery disease. FRISC II prospective randomised multicentre study. Lancet 1999, 354:708\u2013715.","journal-title":"Lancet"},{"key":"27_CR60","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0140-6736(97)11128-X","volume":"352","author":"P Serruys","year":"1998","unstructured":"Serruys P, van Hout B, Bonnier H, et al.: Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease. Lancet 1998, 352:673\u2013681.","journal-title":"Lancet"},{"key":"27_CR61","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1161\/01.CIR.80.5.1176","volume":"80","author":"AF Parisi","year":"1989","unstructured":"Parisi AF, Khuri S, Deupree RH, et al.: Medical compared with surgical management of unstable angina: 5 year mortality and morbidity in the Veterans Administration group. Circulation 1989, 80:1176\u20131189.","journal-title":"Circulation"}],"container-title":["Current Treatment Options in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11936-000-0027-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11936-000-0027-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11936-000-0027-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T20:52:25Z","timestamp":1559422345000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11936-000-0027-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,2]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2000,2]]}},"alternative-id":["27"],"URL":"https:\/\/doi.org\/10.1007\/s11936-000-0027-9","relation":{},"ISSN":["1092-8464","1534-3189"],"issn-type":[{"value":"1092-8464","type":"print"},{"value":"1534-3189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,2]]}}}